AGI (AGBK) reported $45 million in Q3 2026 revenue but incurred a net loss of $119 million, while securing FDA acceptance for its lead gene therapy candidate AG-101 and forming a partnership for a new...
Exodus shares rose 10% after reporting Q3 revenue of $32.5 million, a 7% increase despite an $8.3 million loss. This growth indicates rising user adoption of digital wallets, highlighting the company's...